Ignite Creation Date:
2025-12-24 @ 1:47 PM
Ignite Modification Date:
2026-02-06 @ 1:29 PM
Study NCT ID:
NCT00379795
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2006-09-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
Sponsor:
Genentech, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Choroidal Neovascularization, Age-related Macular Degeneration | View |